|
SFDA issues the No.142 announcement of drug administrative protection
|
|
|
The State Food and Drug Administration (SFDA) issued the No.142 Drug Administrative Protection Announcement on September 8, 2009, declaring the ending of drug administrative protection for Glaxo Wellcome's Seretide Diskus (salmeterol xinafoate / fluticasone propionate) powder for inhalation. | |
|
|
